Literature DB >> 9461487

Mutagenesis of the aspartic acid ligands in human serum transferrin: lobe-lobe interaction and conformation as revealed by antibody, receptor-binding and iron-release studies.

A Mason1, Q Y He, B Tam, R A MacGillivray, R Woodworth.   

Abstract

Recombinant non-glycosylated human serum transferrin and mutants in which the liganding aspartic acid (D) in one or both lobes was changed to a serine residue (S) were produced in a mammalian cell system and purified from the tissue culture media. Significant downfield shifts of 20, 30, and 45 nm in the absorption maxima were found for the D63S-hTF, D392S-hTF and the double mutant, D63S/D392S-hTF when compared to wild-type hTF. A monoclonal antibody to a sequential epitope in the C-lobe of hTF reported affinity differences between the apo- and iron-forms of each mutant and the control. Cell-binding studies performed under the same buffer conditions used for the antibody work clearly showed that the mutated lobe(s) had an open cleft. It is not clear whether the receptor itself may play a role in promoting the open conformation or whether the iron remains in the cleft.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461487      PMCID: PMC1219104          DOI: 10.1042/bj3300035

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Amino-terminal and carboxyl-terminal half-molecules of ovotransferrin: preparation by a novel procedure and their interactions.

Authors:  H Oe; E Doi; M Hirose
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

2.  Structure of human lactoferrin at 3.2-A resolution.

Authors:  B F Anderson; H M Baker; E J Dodson; G E Norris; S V Rumball; J M Waters; E N Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

3.  Abnormal in vitro function of a variant human transferrin.

Authors:  S P Young; A Bomford; A D Madden; R C Garratt; R Williams; R W Evans
Journal:  Br J Haematol       Date:  1984-04       Impact factor: 6.998

4.  Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.

Authors:  R D Klausner; G Ashwell; J van Renswoude; J B Harford; K R Bridges
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

5.  The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes.

Authors:  S P Young; A Bomford; R Williams
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

6.  The effect of salt concentration on the iron-binding properties of human transferrin.

Authors:  J Williams; N D Chasteen; K Moreton
Journal:  Biochem J       Date:  1982-03-01       Impact factor: 3.857

7.  Receptor recognition sites reside in both lobes of human serum transferrin.

Authors:  A B Mason; B M Tam; R C Woodworth; R W Oliver; B N Green; L N Lin; J F Brandts; K J Savage; J A Lineback; R T MacGillivray
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

8.  Differential effect of iodination of ovotransferrin and its two half-molecule domains on binding to transferrin receptors on chick embryo red blood cells.

Authors:  A B Mason; S A Brown
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

9.  Reversible association of half-molecules of ovotransferrin in solution. Basis of co-operative binding to reticulocytes.

Authors:  A Brown-Mason; S A Brown; N D Butcher; R C Woodworth
Journal:  Biochem J       Date:  1987-07-01       Impact factor: 3.857

10.  Transferrin receptors and the uptake and release of iron by isolated hepatocytes.

Authors:  S P Young; P Aisen
Journal:  Hepatology       Date:  1981 Mar-Apr       Impact factor: 17.425

View more
  8 in total

1.  Crystal structures of two mutants (K206Q, H207E) of the N-lobe of human transferrin with increased affinity for iron.

Authors:  A H Yang; R T MacGillivray; J Chen; Y Luo; Y Wang; G D Brayer; A B Mason; R C Woodworth; M E Murphy
Journal:  Protein Sci       Date:  2000-01       Impact factor: 6.725

2.  The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding.

Authors:  Jeremy Wally; Peter J Halbrooks; Clemens Vonrhein; Mark A Rould; Stephen J Everse; Anne B Mason; Susan K Buchanan
Journal:  J Biol Chem       Date:  2006-06-22       Impact factor: 5.157

Review 3.  Transferrin as a model system for method development to study structure, dynamics and interactions of metalloproteins using mass spectrometry.

Authors:  Igor A Kaltashov; Cedric E Bobst; Mingxuan Zhang; Rachael Leverence; Dmitry R Gumerov
Journal:  Biochim Biophys Acta       Date:  2011-06-25

4.  Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments.

Authors:  Paige S Davies; An-Sheng Zhang; Emily L Anderson; Cindy N Roy; Michael A Lampson; Timothy E McGraw; Caroline A Enns
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

5.  Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry.

Authors:  Rachael Leverence; Anne B Mason; Igor A Kaltashov
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

6.  Large cooperativity in the removal of iron from transferrin at physiological temperature and chloride ion concentration.

Authors:  David H Hamilton; Isabelle Turcot; Alain Stintzi; Kenneth N Raymond
Journal:  J Biol Inorg Chem       Date:  2004-10-29       Impact factor: 3.358

7.  Existence of a noncanonical state of iron-bound transferrin at endosomal pH revealed by hydrogen exchange and mass spectrometry.

Authors:  Cedric E Bobst; Mingxuan Zhang; Igor A Kaltashov
Journal:  J Mol Biol       Date:  2009-03-24       Impact factor: 5.469

8.  Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage.

Authors:  Nuria DeGregorio-Rocasolano; Octavi Martí-Sistac; Jovita Ponce; María Castelló-Ruiz; Mònica Millán; Verónica Guirao; Isaac García-Yébenes; Juan B Salom; Pedro Ramos-Cabrer; Enrique Alborch; Ignacio Lizasoain; José Castillo; Antoni Dávalos; Teresa Gasull
Journal:  Redox Biol       Date:  2017-12-02       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.